{
  "pmid": "41469150",
  "title": "Macrophage-Targeted [",
  "abstract": "Anti-tumor necrosis factor (aTNF) treatment of rheumatoid arthritis (RA) requires 3-6 mo to establish efficacy, with 50%-70% response. Quantitative macrophage-targeting PET/CT previously proved to accurately represent RA activity and treatment response. This study investigated early aTNF treatment efficacy assessment using the [",
  "disease": "rheumatoid arthritis"
}